Dermira
Dermira was a biopharmaceutical company focused on medical dermatology, developing and commercializing treatments for chronic skin conditions such as primary axillary hyperhidrosis (Qbrexza / glycopyrronium) and atopic dermatitis (lebrikizumab). Headquartered in Menlo Park, California and originally backed by venture investors including Canaan Partners, the company went public on NASDAQ (DERM) in 2014 and was acquired by Eli Lilly and Company in 2020. Its assets and operations are now part of Eli Lilly; the dermira.com domain redirects to lilly.com. Dermira did not operate a public developer program, API, or developer portal, so this profile carries company identity only and has no API artifacts to enrich.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
Dermira is tracked in the API Evangelist network. This page is the human-readable profile that sits on top of the machine-readable index we maintain at apis.io.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Dermira scores 5.7/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Dermira is in the network as a tracked entity. We haven't yet indexed a public API surface for it — when one is published, the artifacts, score, and agent-readiness read will appear here automatically. The source repository is where that profile is built.
← All providers · Data indexed from github.com/api-evangelist/dermira · machine-readable index on apis.io